Stock Events

Stock Events

Memphasys Limited 

A$0.01
5
-A$0-16.67% Tuesday 02:08

Statistics

Day High
0.01
Day Low
0.01
52W High
0.01
52W Low
0
Volume
1,000,000
Avg. Volume
-
Mkt Cap
13.44M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

28AugExpected
Q4 2021
Q2 2022
Q3 2022
Q4 2022
Q2 2023
Q4 2023
Q2 2024
0
0.33
0.67
1
Expected EPS
N/A
Actual EPS
N/A

Financials

-125,975%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
8,000Revenue
-10.08MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow MEM.AU. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Thermo Fisher Scientific
TMO
Mkt Cap174.55B
Thermo Fisher Scientific offers advanced biotechnology solutions, competing in the life sciences sector similar to Memphasys.
Danaher
DHR
Mkt Cap125.45B
Danaher Corporation operates in the life sciences field, providing technologies that overlap with Memphasys' fertility and biotech focus.
Illumina
ILMN
Mkt Cap19.43B
Illumina, Inc. specializes in genomics, an area that complements the biotechnological advancements pursued by Memphasys.
AGL Energy
AGLXY
Mkt Cap4.71B
Agilent Technologies provides instruments and equipment for labs, directly competing with Memphasys in the biotechnology equipment sector.
Bio-Rad Laboratories
BIO
Mkt Cap7.77B
Bio-Rad Laboratories, Inc. produces specialized technological products for the life science research and clinical diagnostics markets.
Waters
WAT
Mkt Cap30.42B
Waters Corporation offers analytical laboratory instrument systems, directly competing in the biotech instrumentation sector.
Bruker
BRKR
Mkt Cap5.56B
Bruker Corporation designs and manufactures scientific instruments and analytical and diagnostic solutions, competing in the same niche as Memphasys.
Repligen
RGEN
Mkt Cap6.67B
Repligen Corporation provides bioprocessing technologies and systems, which are used in biological drug manufacturing, a field related to Memphasys' activities.
Bio-Techne
TECH
Mkt Cap8.48B
Bio-Techne Corporation develops, manufactures, and sells biotechnology products and clinical calibrators and controls, overlapping with Memphasys' market.

About

Memphasys Limited develops, manufactures, and sells cell and protein separation devices, and related consumables for the healthcare, veterinary, and biotechnology market sectors in Australia. The company offers Felix system, a device separates sperm from raw semen by electrophoresis process and size exclusion membranes. It also provides RoXsta, a rapid in vitro antioxidant assessment; and AI-Port, an ambient temperature semen transport device for artificial insemination in animals. In addition, the company develops ambient temperature storage product for human sperm; and a medium for human sperm isolation, fertilisation and cryopreservation. Memphasys Limited was incorporated in 2006 and is based in Homebush, Australia.
Show more...
CEO
Prof. R. John Aitken Ph.D., ScD FRSE
Country
Australia
ISIN
AU000000MEM5

Listings

MU
DE
IG7.MU
STU
DE
IG7.STU
F
DE
IG7.F
AU
AU
MEM.AU

0 Comments

Share your thoughts

FAQ

What is Memphasys Limited stock price today?▼
The current price of MEM.AU is A$0.01 AUD — it has decreased by -16.67% in the past 24 hours. Watch Memphasys Limited stock price performance more closely on the chart.
What is Memphasys Limited stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Memphasys Limited stocks are traded under the ticker MEM.AU.
What is Memphasys Limited market cap?▼
Today Memphasys Limited has the market capitalization of 13.44M
What is Memphasys Limited revenue for the last year?▼
Memphasys Limited revenue for the last year amounts to 8,000 AUD.
What is Memphasys Limited net income for the last year?▼
MEM.AU net income for the last year is -10.08M AUD.
In which sector is Memphasys Limited located?▼
Memphasys Limited operates in the Health & Wellness sector.
When did Memphasys Limited complete a stock split?▼
The last stock split for Memphasys Limited was on August 16, 2018 with a ratio of 1:15.
Where is Memphasys Limited headquartered?▼
Memphasys Limited is headquartered in Homebush, Australia.